A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Endometriosis

In brief

The purpose of this study is to determine whether tanezumab is effective and safe in the treatment of pain associated with endometriosis.

Key facts

Study ID
NCT00784693
Run by
Pfizer
People needed
48
Starts
2008-12-18
Expected to finish
2010-04-05
Last updated by the study team
2021-04-30

Who can join

Age: 18 and older, up to 49. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.